Alamar grants counsel 29K RSUs, 85K options
Alamar Biosciences granted its general counsel a mix of restricted stock units and stock options that vest over several years, contingent on continued service.
Rhea-AI Filing Summary
Alamar Biosciences, Inc. (ALMR) reported that General Counsel John L. Brottem received equity awards on September 14, 2026. He was granted 29,000 shares of common stock in the form of restricted stock units and 85,000 stock options with an exercise price of $27.99 per share, all held directly.
The restricted stock units vest over roughly six years, with one-quarter vesting on November 21, 2027 and the remainder vesting in twelve equal quarterly installments thereafter, subject to his continuous service. The options expire on September 13, 2036 and vest one-quarter on September 14, 2027, with the balance vesting in 36 equal monthly installments, also contingent on continuous service. No Rule 10b5-1 trading plan is reported for these awards.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 114,000 shares
Grant/Award
2 txns
Insider
Brottem John L.
Role
General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) F2 | 85,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 29,000 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 85,000 contracts (Direct);
Common Stock — 29,000 shares (Direct)
Footnotes (2)
- F1. Represents a restricted stock unit ("RSU") award. One-quarter of the RSUs will vest on November 21, 2027 and the remainder of the RSUs will vest in twelve equal quarterly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
- F2. One-quarter of the total shares subject to the option will vest on September 14, 2027 and the remainder of the shares subject to the grant will vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
Key Figures
Restricted stock units granted: 29,000 shares
Stock options granted: 85,000 options
Stock option exercise price: $27.99 per share
+3 more
6 metrics
Restricted stock units granted
29,000 shares
Common stock RSU award to General Counsel on September 14, 2026
Stock options granted
85,000 options
Employee stock option award to General Counsel on September 14, 2026
Stock option exercise price
$27.99 per share
Exercise price for 85,000 options expiring September 13, 2036
RSU initial vesting date
November 21, 2027
One-quarter of restricted stock units vest on this date
Option initial vesting date
September 14, 2027
One-quarter of stock options vest on this date
Option expiration date
September 13, 2036
Expiration of employee stock option grant
Key Terms
restricted stock unit ("RSU"), vest, continuous service, exercise price
4 terms
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") award."
vest financial
"One-quarter of the RSUs will vest on November 21, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
continuous service financial
"subject to the reporting person's continuous service as of each such vesting date"
exercise price financial
"shares subject to the option will vest on September 14, 2027"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did ALMR grant to General Counsel John L. Brottem?
On September 14, 2026, Alamar Biosciences granted General Counsel John L. Brottem 29,000 restricted stock units and 85,000 stock options for common stock, all held directly, as reported in the insider transaction filing.
What is the exercise price and term of the new ALMR stock options?
The new stock options reported for ALMR carry an exercise price of $27.99 per share and expire on September 13, 2036, providing the general counsel with a long-dated right to purchase common shares if they vest.
How do the 29,000 ALMR restricted stock units vest?
The 29,000 restricted stock units vest with one-quarter on November 21, 2027, and the remaining three-quarters in twelve equal quarterly installments thereafter, subject to John L. Brottem’s continuous service at each vesting date.
What is the vesting schedule for the 85,000 ALMR stock options?
For the 85,000 stock options, one-quarter vests on September 14, 2027, with the remaining shares vesting in 36 equal monthly installments after that date, conditioned on the reporting person’s continuous service at each vesting date.
Were the ALMR equity awards to the general counsel issued under a Rule 10b5-1 plan?
No. The Form 4 indicates that no Rule 10b5-1 trading plan is reported in connection with these equity awards to Alamar Biosciences’ general counsel.
AI-generated analysis. How Rhea-AI works. Not financial advice.
